Overview
BAY 0 9867 Cipro Pediatric Use Study (QUIP)
Status:
Completed
Completed
Trial end date:
2008-01-01
2008-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Objective and subjective musculoskeletal evaluations will be performed to determine differences in the ciprofloxacin versus non-quinolone treated pediatric patients so that we can tell what the natural occurrence of such musculoskeletal conditions is in the general pediatric population.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
BayerTreatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Ciprofloxacin
Criteria
Inclusion Criteria:- Patient is >/= 2 months of age through 16 years of age
- A parent/caregiver must sign an informed consent
- Patient must provide assent, as appropriate based on local institutional review board
guidelines
Exclusion Criteria:
- Patients presenting with the following conditions:
- exacerbations of cystic fibrosis (CF)
- meningitis
- Brain abscess
- bacterial endocarditis,
- Bone and joint infections
- having any of the following conditions but lacking a personal history may be admitted
to the trial:
- Arthritis
- Juvenile rheumatoid arthritis (JRA)
- Rheumatoid arthritis (RA)
- Systemic lupus erythematosis (SLE)
- History of rheumatic fever
- Psoriasis
- Inflammatory bowel disease
- Osteoarthritis (OA)
- Known underlying rheumatological disease, joint problems known to be associated with
arthropathy.
- Patients with any pre-treatment baseline musculoskeletal exam abnormalities
- Known risk of experiencing seizures, a history of any convulsive disorders
- Requiring any concomitant therapeutic course of systemic antibacterial agent
- Participation in any industry-sponsored clinical drug development study within one
month prior to this study
- Known significant liver impairment (ALAT/ASAT and/or baseline bilirubin > 3 times
upper limit of normal)
- Known significant renal insufficiency (calculated creatinine clearance of < 30
ml/min/1.73 m²)
- Are pregnant or lactating, or are sexually active and using unreliable contraception.